Unleash the power of our people

Collaborating to Raise Awareness of ATTR-CM

In honor ofWorld Heart Day, Pfizer partnered with the World Heart Federation on its“Heart Hero” campaign and contributed educational information and resources on transthyretin amyloid cardiomyopathy (ATTR-CM) to help raise awareness of this rare, fatal and underdiagnosed cause of heart failure. We also drummed up support with the help of more than 700 Amyloidosis Heart Heroes, who made personal promises to help drive better understanding of the disease. Our work does not end here, as we continue beyond World Heart Day toincrease awareness of the “red flag” signs and symptoms and help to ensure those living with ATTR-CM are appropriatelydiagnosed.
Unleash the power of our people
Deliver first-in-class science
Transform our go-to-market model
Win the digital race in pharma
Lead the conversation